We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Hand Hygiene Noncompliance and the Cost of Hospital-Acquired MRSA Infection

By HospiMedica International staff writers
Posted on 21 Apr 2010
A new study shows that even minimal improvements in hand hygiene compliance is associated with significant and substantial savings in hospital costs. More...


Researchers at Duke University Medical Center (Durham, NC, USA) created two models to simulate sequential patient contacts by a hand hygiene-noncompliant healthcare worker. The first model involved encounters with patients of unknown methicillin-resistant Staphylococcus aureus (MRSA) status; the second model involved an encounter with an MRSA-colonized patient, followed by an encounter with a patient of unknown MRSA status. The probability of new MRSA infection for the second patient was then calculated using published data. In all, a simulation of one million noncompliant events was performed; the total costs of the resulting infections were then aggregated and amortized over all events. Estimates of MRSA prevalence, probability of transmission, and subsequent infection were derived from the published literature and experience at the study institution.

The results showed that the first model was associated with 42 MRSA infections, an infection rate of 0.0042%; the mean infection cost was US$47,092; and the mean cost per noncompliant event was $1.98. In the second model, noncompliance was associated with 980 MRSA infections, an infection rate of 0.098%; the mean infection cost was $53,598; the mean cost per noncompliant event was $52.53. Based on these figures, a 200-bed hospital incurs a total of $1,779,283 in annual MRSA infection-related expenses that are directly attributable to hand hygiene noncompliance. According to the researchers, a mere 1% increase in hand hygiene compliance would result in annual savings of $39,650; an increase in hand hygiene adherence by 5% would result in a mean decrease in expected MRSA-related costs of $198,250. The study was published in the April 2010 issue of Infection Control and Hospital Epidemiology.

"Many other pathogens are also spread to patients on the hands of healthcare workers as a result of noncompliance with hand hygiene. In fact, in some reports MRSA accounts for fewer than 8% of all hospital-acquired infections,” concluded lead author Keith Cummings, M.D., and colleagues of the department of medicine. "Because our model focused on costs associated only with MRSA transmission, it substantially underestimated the costs associated with hand hygiene noncompliance.”

Related Links:
Duke University Medical Center



Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Tourniquet System
heidi– mein Tourniquet
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: The tool analyzes 3D time-of-flight MR angiography to measure brain vessel length, radius, volume, branching, tortuosity, and other structural features. (Photo courtesy of University of Rochester Medical Center)

MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease

Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.